Log In   |  Register Free Newsletter Subscription
Skip navigation
Zibb
Subscribe to Manufacturing Business Technology
FirstLight 
Email
Print
Reprints/License
RSS

Takeda deploys electronic batch system on drug manufacturing line

By Manufacturing Business Technology Staff -- Manufacturing Business Technology, 3/28/2008 5:30:00 PM

Takeda Ireland Limited (TIL), a subsidiary of Takeda Pharmaceutical Corp., reports deployment of an electronic batch record (EBR) system on a key production line using Elan Software’s XFP-MES (manufacturing execution system).
With a state-of-the-art manufacturing facility, Takeda was eager to implement a cost-reduction strategy while improving operational performance and quality. Process automation, decreased human error, improved yield, faster batch review, lower paper volume, secure archiving, and visibility into tasks to be performed and executed were among the key objectives.
TIL says it is now in the design stages of a second EBR production line, using XFP-MES to manage the entire production cycle from raw materials receipt to shipping finished products. The XFP implementation includes material flow management, weighing and dispensing, directed manufacturing, equipment management, electronic batch records, and packaging.
“Takeda Ireland is a fine example of an innovative drug manufacturer that is leveraging technology to address cost-reduction strategy, but at the same time focus on increasing operation performance and delivering qualitative products to its customers," says JP Amadio, managing director, Elan Software.

Email
Print
Reprints/License
RSS
Talkback
Reed Business Information Resource Center

Featured Company


Related Resources

Advertisement

Related Microsite Content

Related Links

Advertisement

NEWSLETTERS
Mid-Day Report
Innovation Strategies
Intelligent Manufacturing
Lean Enterprise



Please read our Privacy Policy

About Us   |   Advertising Info   |   Site Map   |   Contact Us   |   FREE Subscription   |   Affiliate Links   |   RSS
© 2009 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.
Use of this Web site is subject to its Terms of Use | Privacy Policy
Please visit these other Reed Business sites